financetom
Business
financetom
/
Business
/
Angel Studios Q3 Loss Widens, Revenue Rises; Shares Gain After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Angel Studios Q3 Loss Widens, Revenue Rises; Shares Gain After Hours
Nov 13, 2025 2:12 PM

04:57 PM EST, 11/13/2025 (MT Newswires) -- Angel Studios ( ANGX ) reported a Q3 loss late Thursday of $0.25 per diluted share, widening from the loss of $0.10 a year earlier.

One analyst surveyed by FactSet expected a loss of $0.26.

Revenue in the three months ended Sept. 30 rose to $76.5 million from $20.1 million a year earlier.

One analyst polled by FactSet expected $71.6 million.

Angel shares rose 4.1% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Bioventus' Two Nerve Stimulation Devices Get FDA 510(k) Clearance; Shares Rise
Bioventus' Two Nerve Stimulation Devices Get FDA 510(k) Clearance; Shares Rise
Jul 30, 2025
10:31 AM EDT, 07/30/2025 (MT Newswires) -- Bioventus ( BVS ) said Wednesday that the US Food and Drug Administration has given 510(k) clearances for TalisMann and StimTrial, the company's peripheral nerve stimulation, or PNS, devices for chronic pain management. TalisMann targets deeper, larger nerves and is designed to provide long-term relief from chronic nerve pain. StimTrial allows doctors to...
Celcuity Prices Public Offerings of Convertible Notes, Common Shares
Celcuity Prices Public Offerings of Convertible Notes, Common Shares
Jul 30, 2025
10:31 AM EDT, 07/30/2025 (MT Newswires) -- Celcuity ( CELC ) said Wednesday it has priced underwritten public offerings of its 2.750% convertible senior notes due 2031, and nearly 1.84 million common shares at $38 each or pre-funded warrants to buy up to 400,000 shares. Underwriters have a 30-day option to buy up to an additional $26.3 million principal amount...
Solaris Energy Reports Dual Listing on NYSE Texas
Solaris Energy Reports Dual Listing on NYSE Texas
Jul 30, 2025
10:30 AM EDT, 07/30/2025 (MT Newswires) -- Solaris Energy Infrastructure ( SEI ) reported Wednesday the dual listing of its Class A shares on NYSE Texas, a newly launched electronic equities exchange in Dallas, Texas. Solaris said it will keep its primary listing on the New York Stock Exchange and continue to trade under the same SEI ticker. Price: 34.08,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved